Rowa Mohammed Assayaghi

Comparison of sustained virologic responses to ledipasvir/sofosbuvir plus ribavirin therapy between previously treated and naïve patients with chronic hepatitis c in yemen: a retrospective comparative cohort study

Abstract Background Hepatitis C virus (HCV) infection remains a major global health burden, with high prevalence in the Eastern Mediterranean region, including Yemen. Direct-acting antivirals (DAAs) such as ledipasvir/sofosbuvir (LDV/SOF) combined with ribavirin have demonstrated...